Immediate Impact
50 standout
Citing Papers
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Adel Nada being referenced
Studying navitoclax, a targeted anticancer drug, in healthy volunteers--ethical considerations and risk/benefit assessments and management.
2014
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Adel Nada | 42 | 83 | 123 | 133 | 84 | 30 | 456 | |
| Yijie Hu | 13 | 28 | 82 | 150 | 102 | 35 | 509 | |
| Feng Ran | 17 | 28 | 184 | 113 | 24 | 32 | 467 | |
| Michael Neumeier | 73 | 27 | 43 | 96 | 98 | 12 | 494 | |
| Justin Lowenthal | 51 | 30 | 58 | 169 | 155 | 15 | 452 | |
| Marcel Costuleanu | 12 | 8 | 53 | 127 | 26 | 40 | 416 | |
| Kimihiro Suzuki | 71 | 57 | 29 | 106 | 49 | 51 | 491 | |
| Albert Rabinovitch | 12 | 16 | 179 | 112 | 15 | 18 | 500 | |
| E Constantinescu | 14 | 11 | 59 | 142 | 32 | 37 | 493 | |
| Naoki Makita | 49 | 33 | 38 | 209 | 28 | 39 | 491 | |
| Chao Tang | 7 | 12 | 54 | 169 | 31 | 33 | 494 |
All Works
Loading papers...